Franklin Resources’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$319M Buy
3,448,193
+86,646
+3% +$8.7M 0.08% 237
2025
Q4
$343M Buy
3,361,547
+435,232
+15% +$38.9M 0.08% 216
2025
Q3
$183M Buy
2,926,315
+606,368
+26% +$33M 0.05% 320
2025
Q2
$121M Buy
2,319,947
+1,018,144
+78% +$45.5M 0.03% 400
2025
Q1
$55.5M Buy
1,301,803
+361,757
+38% +$15.6M 0.02% 573
2024
Q4
$28.7M Sell
940,046
-5,979
-0.6% -$168K 0.01% 797
2024
Q3
$20.2M Sell
946,025
-123,938
-12% -$3.51M 0.01% 893
2024
Q2
$30.9M Buy
1,069,963
+2,702
+0.3% +$62.9K 0.01% 712
2024
Q1
$22M Sell
1,067,261
-301,748
-22% -$6.47M 0.01% 834
2023
Q4
$37M Buy
1,369,009
+131,646
+11% +$3.45M 0.02% 597
2023
Q3
$36.7M Buy
1,237,363
+5,244
+0.4% +$184K 0.02% 579
2023
Q2
$44.1M Buy
1,232,119
+32,055
+3% +$921K 0.02% 560
2023
Q1
$28.1M Sell
1,200,064
-500,130
-29% -$14.3M 0.01% 684
2022
Q4
$46.2M Sell
1,700,194
-1,261,202
-43% -$57.7M 0.02% 549
2022
Q3
$159M Buy
2,961,396
+191,898
+7% +$9.85M 0.09% 277
2022
Q2
$112M Buy
2,769,498
+157,961
+6% +$7.83M 0.06% 360
2022
Q1
$173M Buy
2,611,537
+1,229,021
+89% +$84.1M 0.07% 325
2021
Q4
$138M Sell
1,382,516
-369,428
-21% -$38.2M 0.05% 382
2021
Q3
$219M Buy
1,751,944
+31,819
+2% +$3.78M 0.08% 277
2021
Q2
$214M Sell
1,720,125
-91,066
-5% -$12.2M 0.08% 276
2021
Q1
$276M Buy
1,811,191
+191,472
+12% +$28.9M 0.11% 220
2020
Q4
$209M Buy
1,619,719
+293,670
+22% +$33.8M 0.09% 252
2020
Q3
$148M Buy
1,326,049
+429,441
+48% +$39.3M 0.07% 289
2020
Q2
$74.3M Sell
896,608
-22,816
-2% -$1.84M 0.04% 455
2020
Q1
$64M Sell
919,424
-5,547
-0.6% -$426K 0.04% 406
2019
Q4
$72.3M Buy
924,971
+254,288
+38% +$18.3M 0.04% 450
2019
Q3
$42.8M Sell
670,683
-112,089
-14% -$9.87M 0.02% 571
2019
Q2
$67.6M Sell
782,772
-253,292
-24% -$19.3M 0.04% 480
2019
Q1
$79.4M Sell
1,036,064
-183,884
-15% -$10.2M 0.04% 424
2018
Q4
$45.9M Buy
+1,219,948
New +$44.9M 0.03% 497

Other funds holding GH

Franklin Resources's GH Position: Q1 2026 in Review

Franklin Resources increased its Guardant Health (GH) stake by 2.6% in Q1 2026, buying an estimated $8.7M and bringing the position to 3,448,193 shares worth $319M. The position accounts for 0.08% of the portfolio, ranked #237.

Franklin Resources first reported a position in GH in Q4 2018 and has held it in 30 quarters since. The position peaked at $343M in Q4 2025. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Franklin Resources held 3,448,193 shares of Guardant Health worth $319M as of Q1 2026.
  • Franklin Resources bought 86,646 Guardant Health shares in Q1 2026, an estimated $8.7M.
  • Guardant Health made up 0.08% of Franklin Resources's portfolio in Q1 2026, its #237 holding.
  • Franklin Resources first reported a position in Guardant Health in Q4 2018 and has held it in 30 quarters since.
  • Franklin Resources's Guardant Health position peaked at $343M in Q4 2025.
  • 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Franklin Resources's 13F filing for Q1 2026, filed 13 May 2026.